Filing Details
- Accession Number:
- 0001742428-21-000002
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-05-20 17:23:42
- Reporting Period:
- 2021-05-18
- Accepted Time:
- 2021-05-20 17:23:42
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1688757 | Establishment Labs Holdings Inc. | ESTA | Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842) | 981436377 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1742428 | Renee Gaeta | C/O Motiva Usa Llc 16192 Coastal Highway Lewes DE 19958 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Shares | Acquisiton | 2021-05-18 | 100 | $10.19 | 100 | No | 4 | M | Direct | |
Common Shares | Disposition | 2021-05-18 | 100 | $74.00 | 0 | No | 4 | S | Direct | |
Common Shares | Acquisiton | 2021-05-19 | 800 | $10.19 | 800 | No | 4 | M | Direct | |
Common Shares | Disposition | 2021-05-19 | 800 | $74.31 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Shares | Stock Option (Right to buy) | Disposition | 2021-05-18 | 100 | $10.19 | 100 | $10.19 |
Common Shares | Stock Option (Right to buy) | Disposition | 2021-05-19 | 800 | $10.19 | 800 | $10.19 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
147,020 | 2028-03-13 | No | 4 | M | Direct | |
146,220 | 2028-03-13 | No | 4 | M | Direct |
Footnotes
- The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person.
- This transaction was executed in multiple trades at prices ranging from $74.00 to $74.61 per share. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- The option, originally for 147,120 shares, vested as to one-fourth of the shares on July 1, 2018, and one-fourth of the shares subject to the option vest each one-year anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date.